Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

41.17
-0.0050-0.01%
Volume:1.71M
Turnover:70.55M
Market Cap:47.96B
PE:68.61
High:41.64
Open:41.30
Low:41.05
Close:41.17
52wk High:42.02
52wk Low:18.83
Shares:1.17B
Float Shares:1.09B
Volume Ratio:0.65
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:6.19
PE(LYR):34.02

Loading ...

Barclays Sticks to Their Buy Rating for Teva (TEVA)

TIPRANKS
·
10 hours ago

Leader Capital Markets Reaffirms Their Buy Rating on Teva (TEVA)

TIPRANKS
·
14 hours ago

Teva Pharmaceuticals is Maintained at Overweight by JP Morgan

Dow Jones
·
20 hours ago

Teva : Oppenheimer Raises Target Price to $52 from $50

THOMSON REUTERS
·
Yesterday

Collegium Pharmaceutical Outlook Supported by ADHD Trends, Low Generic Drug Risk, Oppenheimer Says

MT Newswires Live
·
Oct 10

Teva Pharmaceutical on Track for Highest Close Since February 2017

Dow Jones
·
Oct 10

Teva's Weltruza Seen as Launch-Execution Story After Clean Label, Oppenheimer Says

MT Newswires Live
·
Oct 10

Oppenheimer Adjusts Teva Pharmaceutical Industries PT to $52 From $50, Maintains Outperform Rating

MT Newswires Live
·
Oct 10

Pharma Stocks Jump With Novavax up 12%, Moderna up 6%

Tiger Newspress
·
Oct 09

Movement Alert|Teva Pharmaceutical Rises 5.05% in Regular Trading, FDA Approves WELTRUZA for Schizophrenia

Market Focus
·
Oct 09

Bank of America Securities Sticks to Its Buy Rating for Teva (TEVA)

TIPRANKS
·
Oct 09

Teva Pharmaceutical Industries Says FDA Approved WELTRUZA for Schizophrenia in Adults

MT Newswires Live
·
Oct 09

Teva announces FDA approval for Weltruza

TIPRANKS
·
Oct 09

Teva call volume above normal and directionally bullish

TIPRANKS
·
Oct 08

Scotiabank Keeps Their Buy Rating on Teva (TEVA)

TIPRANKS
·
Oct 02

Teva: Additional Analyses Found That Common Concurrent Psychiatric Conditions Did not Negatively Impact Ecopipam's Efficacy or Safety

THOMSON REUTERS
·
Oct 02

Update: Teva, Samsung Bioepis Partner to Develop, Commercialize Biosimilar Candidates

MT Newswires Live
·
Oct 02

TD Cowen Initiates Teva Pharmaceutical Industries at Buy With $55 Price Target

MT Newswires Live
·
Oct 01

Teva initiated with a Buy at TD Cowen

TIPRANKS
·
Oct 01

Teva, Samsung Bioepis Partner to Develop and Commercialize Biosimilar Candidates

MT Newswires Live
·
Oct 01